etoposide has been researched along with vitamin k semiquinone radical in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hochman, A; Kessler-Icekson, G; Koren, R; Liberman, UA; Machlenkin, A; Ravid, A; Rocker, D; Rotem, C | 1 |
Aoyagi, T; Eguchi, K; Ejima, E; Hida, A; Ichinose, Y; Kawabe, Y; Kawakami, A; Migita, K; Nakamura, H; Nakamura, T; Nakashima, T; Tsuboi, M; Urayama, S; Yamasaki, S | 1 |
2 other study(ies) available for etoposide and vitamin k semiquinone radical
Article | Year |
---|---|
1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage.
Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Female; Humans; Reactive Oxygen Species; Superoxide Dismutase; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vitamin K | 1999 |
Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine.
Topics: Apoptosis; Cell Division; Cell Line; Coculture Techniques; Cysteine Endopeptidases; DNA; Enzyme Inhibitors; Etoposide; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; Immunoglobulin M; Membrane Glycoproteins; Multienzyme Complexes; Osteoblasts; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Transformation, Genetic; Tumor Necrosis Factor-alpha; Vitamin K | 2000 |